Selective structure-based virtual screening for full and partial agonists of the β2 adrenergic receptor

被引:115
|
作者
de Graaf, Chris [1 ]
Rognan, Didier [1 ]
机构
[1] Univ Louis Pasteur Strasbourg 1, Inst Gilbert Laustriat, CNRS, UMR 7175,LCI, F-67401 Illkirch Graffenstaden, France
关键词
D O I
10.1021/jm800710x
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The recently solved high-resolution X-ray structure of the beta 2 adrenergic receptor has been challenged for its ability to discriminate inverse agonists/antagonists from partial/full agonists. Whereas the X-ray structure of the ground state receptor was unsuitable to distinguish true ligands with different functional effects, modifying this structure to reflect early conformational events in receptor activation led to a receptor model able to selectively retrieve full and partial agonists by structure-based virtual screening. The use of a topological scoring function based on molecular interaction fingerprints was shown to be mandatory to properly rank docking poses and achieve acceptable enrichments for partial and full agonists only.
引用
收藏
页码:4978 / 4985
页数:8
相关论文
共 50 条
  • [1] Selective Structure-Based Virtual Screening for Full and Partial Agonists of the β2 Adrenergic Receptor (vol 51, pg 4978, 2008)
    de Graaf, Chris
    Rognan, Didier
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (20) : 6620 - 6620
  • [2] Elucidation of partial activation of cannabinoid receptor type 2 and identification of potential partial agonists: Molecular dynamics simulation and structure-based virtual screening
    Uba, Abdullahi Ibrahim
    Aluwala, Harika
    Liu, Haiguang
    Wu, Chun
    COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2022, 99
  • [3] Structure-Based Virtual Screening and Molecular Dynamics Simulation Assessments of Depsidones as Possible Selective Cannabinoid Receptor Type 2 Agonists
    Mohamed, Gamal A.
    Omar, Abdelsattar M.
    AlKharboush, Dana F.
    Fallatah, Mona A.
    Sindi, Ikhlas A.
    El-Agamy, Dina S.
    Ibrahim, Sabrin R. M.
    MOLECULES, 2023, 28 (04):
  • [4] Identification of nonpeptide CCR5 receptor agonists by structure-based virtual screening
    Kellenberger, Esther
    Springael, Jean-Yves
    Parmentier, Marc
    Hachet-Haas, Muriel
    Galzi, Jean-Luc
    Rognan, Didier
    JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (06) : 1294 - 1303
  • [5] A Combined Ligand- and Structure-Based Virtual Screening Protocol Identifies Submicromolar PPARγ Partial Agonists
    Vidovic, Dusica
    Busby, Scott A.
    Griffin, Patrick R.
    Schuerer, Stephan C.
    CHEMMEDCHEM, 2011, 6 (01) : 94 - 103
  • [6] Structure-based discovery of potent and selective melatonin receptor agonists
    Patel, Nilkanth
    Huang, Xi Ping
    Grandner, Jessica M.
    Johansson, Linda C.
    Stauch, Benjamin
    McCorvy, John D.
    Liu, Yongfeng
    Roth, Bryan
    Katritch, Vsevolod
    ELIFE, 2020, 9
  • [7] Cell-based and virtual fragment screening for adrenergic α2C receptor agonists
    Szollosi, Edit
    Bobok, Amrita
    Kiss, Laszlo
    Vass, Marton
    Kurko, Dalma
    Kolok, Sandor
    Visegrady, Andras
    Keseru, Gyoergy M.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (14) : 3991 - 3999
  • [8] Predicting the duration of action of β2-adrenergic receptor agonists: Ligand and structure-based approaches
    Chiesa, Luca
    Sick, Emilie
    Kellenberger, Esther
    MOLECULAR INFORMATICS, 2023, 42 (12)
  • [9] Selective ligands of estrogen receptor β discovered using pharmacophore mapping and structure-based virtual screening
    Chen, Lei
    Wu, Dang
    Bian, Han-ping
    Kuang, Guang-lin
    Jiang, Jing
    Li, Wei-hua
    Liu, Gui-xia
    Zou, Shi-en
    Huang, Jin
    Tang, Yun
    ACTA PHARMACOLOGICA SINICA, 2014, 35 (10) : 1333 - 1341
  • [10] Structure-based virtual screening discovers potent and selective adenosine A1 receptor antagonists
    Matricon, Pierre
    Nguyen, Anh T. N.
    Vo, Duc Duy
    Baltos, Jo-Anne
    Jaiteh, Mariama
    Luttens, Andreas
    Kampen, Stefanie
    Christopoulos, Arthur
    Kihlberg, Jan
    May, Lauren Therese
    Carlsson, Jens
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 257